Monday, January 22, 2018 5:10:33 PM
ANDA
CARE..implemented model going forward..Pharmacist involvement
Monday Pharmaceuticals
FDA clearance Knee and foot
Back study trial submittal
Back study data positive
Back study better collaborative FDA communication for approval
Performance Health ..HUGE
NHS reimbursement..HUGE
Incoming inquiries from all direction..Huge
Price entry..No brainer!
Baby Boomers..here they come.
Baseline sales..vs. 2018 potential..Huge
Pain epidemic market..Huge
Opiate crisis..Huge
Why are we still struggling with .009 to .0010?
SEC elephant in the room...Huge
20 Billion share structure...Huge
Not yet full clearance..Huge
Current UK lack of sales...Huge
Current lack of sales USA..knee and foot clearance by FDA..Huge
Pending possible RS ..Huge
I'll stop there. However, the price stagnation with even very positive news renders looking at this equity from both sides. Remember, we are still a pinky.
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM